APA (7th ed.) Citation

MS, V., AM, B., S, S., KC, P., S, G., JW, D., . . . WD, M. (2023). Development of a Peripherally Restricted 5-HT2B Partial Agonist for Treatment of Pulmonary Arterial Hypertension. JACC. Basic to translational science, 8(10), 1379. https://doi.org/10.1016/j.jacbts.2023.06.014

Chicago Style (17th ed.) Citation

MS, Valentine, et al. "Development of a Peripherally Restricted 5-HT2B Partial Agonist for Treatment of Pulmonary Arterial Hypertension." JACC. Basic to Translational Science 8, no. 10 (2023): 1379. https://doi.org/10.1016/j.jacbts.2023.06.014.

MLA (9th ed.) Citation

MS, Valentine, et al. "Development of a Peripherally Restricted 5-HT2B Partial Agonist for Treatment of Pulmonary Arterial Hypertension." JACC. Basic to Translational Science, vol. 8, no. 10, 2023, p. 1379, https://doi.org/10.1016/j.jacbts.2023.06.014.